Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin H Cohen

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
The Oncologist|October 29, 2002
U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acidMartin H Cohen, Ramzi Dagher, Donna J Griebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tabletsMartin H Cohen, Grant A Williams, Rajeshwari Sridhara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemiaMartin H Cohen, Grant Williams, John R Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphomaMartin H Cohen, John R Johnson, Tristan Massie, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
The Oncologist|October 29, 2002
U.S. Food and Drug Administration drug approval summaries: imatinib mesylate, mesna tablets, and zoledronic acidMartin H Cohen, Ramzi Dagher, Donna J Griebel, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
United States Food and Drug Administration Drug Approval summary: Gefitinib (ZD1839; Iressa) tabletsMartin H Cohen, Grant A Williams, Rajeshwari Sridhara, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 15, 2002
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemiaMartin H Cohen, Grant Williams, John R Johnson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 27, 2006
Approval summary: nelarabine for the treatment of T-cell lymphoblastic leukemia/lymphomaMartin H Cohen, John R Johnson, Tristan Massie, et al.
Pageof 4